Amid a push to bulk up in Latin America, Procaps buys Mexican drugmaker Grupo Somarnews2022-05-19T12:19:08+00:00May 19th, 2022|Fierce Pharma|
Johnson & Johnson gets pulmonary hypertension nurses talking with live online educational campaignnews2022-05-19T11:34:41+00:00May 19th, 2022|Fierce Pharma|
Troubles for Bayer and AbbVie? Their market cap in Q1 tells a different story: reportnews2022-05-19T11:03:01+00:00May 19th, 2022|Fierce Pharma|
After high-profile US rejection for roxadustat, Astellas touts its safety in new pooled analysisnews2022-05-19T00:22:57+00:00May 19th, 2022|Fierce Pharma|
NIH in talks with Pfizer to study a longer course of COVID drug Paxlovid, Fauci saysnews2022-05-18T20:12:51+00:00May 18th, 2022|Fierce Pharma|
‘Pharma bro’ Shkreli no longer behind bars—but his lifetime industry ban remains in placenews2022-05-18T20:01:12+00:00May 18th, 2022|Fierce Pharma|
Moderna chairman Afeyan defends hiring practices after CFO debacle: reportnews2022-05-18T15:18:46+00:00May 18th, 2022|Fierce Pharma|
Pfizer holding on tight to supplies of COVID-19 drug Paxlovid, limiting the prospect of combination research: reportnews2022-05-18T14:36:56+00:00May 18th, 2022|Fierce Pharma|
Roche, bluebird bio settle gene therapy trademark suit around ‘spark’ sickle cell disease campaignnews2022-05-18T14:33:09+00:00May 18th, 2022|Fierce Pharma|
J&J partner Aspen, with no orders for its COVID shot, warns low demand sends ‘bad message’news2022-05-18T13:13:40+00:00May 18th, 2022|Fierce Pharma|
